Compare ARK Genomic Revolution ETF (ARKG) vs Badger Meter Inc (BMI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Badger Meter Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Badger Meter Inc trades at $144.18 (market cap $4.21B). The key difference: Badger Meter Inc pays a 1.11% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Badger Meter Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | BMI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $245.81 |
52-Week Low | $23.09 | $113.41 |
Market Cap | — | $4.21B |
Enterprise Value | — | $4.00B |
Dividend Yield | — | 1.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Badger Meter (BMI) trades at $144.18, down 0.54% today, with a bullish technical outlook supported by moving averages and strong ADX readings. The company maintains solid profitability with 14.56% net margin and 19.6% ROE, though recent earnings misses and a securities class action lawsuit create near-term uncertainty. Revenue declined to $897M in 2026 from $917M in 2025, while cash flow improved to positive $74M.
BMI presents a mixed investment case with strong fundamentals offset by legal risks. The stock trades near analyst consensus target of $144.80, offering limited upside. While operational metrics remain healthy, the pending class action and recent earnings volatility warrant caution. Institutional sentiment leans neutral with 55.55% hold ratings, suggesting investors await legal resolution and earnings stabilization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →
